Matinas BioPharma
MTNB
#10023
Rank
โ‚ฌ2.81 M
Marketcap
0,55ย โ‚ฌ
Share price
7.39%
Change (1 day)
-94.35%
Change (1 year)

Earnings for Matinas BioPharma (MTNB)

Earnings in 2024 (TTM): -โ‚ฌ21.26 Million

According to Matinas BioPharma's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ21.91 Million a decrease over its 2022 earnings that were of -โ‚ฌ20.06 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Matinas BioPharma from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ21.26 Million-2.98%
2023 -โ‚ฌ21.91 Million9.26%
2022 -โ‚ฌ20.06 Million-9.82%
2021 -โ‚ฌ22.24 Million3.73%
2020 -โ‚ฌ21.44 Million29.21%
2019 -โ‚ฌ16.59 Million19.07%
2018 -โ‚ฌ13.94 Million-7.91%
2017 -โ‚ฌ15.13 Million108.5%
2016 -โ‚ฌ7.26 Million-16.82%
2015 -โ‚ฌ8.73 Million-10.62%
2014 -โ‚ฌ9.77 Million175.27%
2013 -โ‚ฌ3.55 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.12 Billion 446.08%๐Ÿ‡บ๐Ÿ‡ธ USA